Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Complement Factor H Antikörper

Der Maus Monoklonal Anti-Complement Factor H-Antikörper wurde für WB, EIA und IHC (fro) validiert. Er ist geeignet, Complement Factor H in Proben von Ratte und Maus zu detektieren.
Produktnummer ABIN5540274

Kurzübersicht für Complement Factor H Antikörper (ABIN5540274)

Target

Alle Complement Factor H (CFH) Antikörper anzeigen
Complement Factor H (CFH)

Reaktivität

  • 79
  • 14
  • 13
  • 3
  • 2
Ratte, Maus

Wirt

  • 64
  • 32
  • 3
  • 2
Maus

Klonalität

  • 60
  • 40
  • 1
Monoklonal

Konjugat

  • 64
  • 12
  • 7
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Dieser Complement Factor H Antikörper ist unkonjugiert

Applikation

  • 78
  • 49
  • 32
  • 32
  • 26
  • 17
  • 14
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))

Klon

1A2
  • Spezifität

    The monoclonal antibody 1A2 recognizes Mouse complement factor H (CFH).

    Aufreinigung

    Purified

    Immunogen

    Mouse factor H-human IgG fusion protein.

    Isotyp

    IgG1
  • Applikationshinweise

    Immuno Assays. Western blot . Immunohistochemistry on Frozen Sections The typical starting working dilution is 1/50.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Buffer System: PBS Preservatives: 0.02 % Sodium Azide Stabilizers: 0.1 % BSA

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store undiluted at 2-8°C. DO NOT FREEZE! Shelf life: one year from despatch.

    Haltbarkeit

    12 months
  • Target

    Complement Factor H (CFH)

    Hintergrund

    CFH is the first regulatory protein of the alternative pathway of the complement system. There are three pathways of complement activation classical, alternative, and lectin activation pathway. These pathways converge to form C3/C5 convertases that generate C3a, C3b,C5a, and C5b, each with substantial biologic activity. Complement regulators are necessary to prevent the injudicious production of these mediators and potential injury to self-tissue. The plasma proteins CFH, C4-binding protein and the cell membrane proteins complement receptor 1 (CR1 CD35), decay-accelerating factor (CD55), and membrane co-factor protein (CD46) all are members of the regulators of complement activation family. These proteins have natural affinity for C3b and/or C4b, which confers on them the ability to accelerate the intrinsic decay of C3/C5 convertases and/or act as co-factor for the cleavage and inactivation (i) of C3b and C4b by complement factor I (CFI). Genetic human analyses reveals a clear association of CFH with different human diseases. These include diseases of the kidney, the atypical form of Hemolytic Uremic Syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN). Furthermore, CFH is associated with age-related macular degeneration (AMD), a disease of the eye.

    UniProt

    P06909

    Pathways

    Komplementsystem, Cellular Response to Molecule of Bacterial Origin
Sie sind hier:
Chat with us!